Anaemia Clinical Trials

33 recruitingLast updated: June 18, 2026

There are 33 actively recruiting anaemia clinical trials across 25 countries. Studies span Phase 3, Phase 2, Phase 4, Not Applicable, Phase 1. Top locations include San Antonio, Texas, United States, Tianjin, Tianjin Municipality, China, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Anaemia Trials at a Glance

33 actively recruiting trials for anaemia are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Phase 3 with 10 trials, with the heaviest enrollment activity in San Antonio, Tianjin, and Beijing. Lead sponsors running anaemia studies include Institute of Hematology & Blood Diseases Hospital, China, CHRISTUS Health, and Austin Health.

Browse anaemia trials by phase

Treatments under study

About Anaemia Clinical Trials

Looking for clinical trials for Anaemia? There are currently 46 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Anaemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Anaemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 33 trials

Recruiting
Phase 3

A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

Autoimmune Haemolytic Anaemia
Sanofi90 enrolled95 locationsNCT07086976
Recruiting
Phase 1

IASO-782 in Autoimmune Hematological Diseases

Autoimmune ThrombocytopeniaWarm Autoimmune Haemolytic Anaemia
Shanghai IASO Biotechnology Co., Ltd16 enrolled2 locationsNCT06534021
Recruiting
Not Applicable

The Use of Robot Assisted Magnetically Controlled Capsule Endoscopy in Patients With Iron Deficiency Anaemia

Iron deficiency anaemia
University of Edinburgh100 enrolled1 locationNCT07197424
Recruiting
Phase 3

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

Iron deficiency anaemiaPeritoneal DialysisAnaemia
Hull University Teaching Hospitals NHS Trust30 enrolled1 locationNCT06884280
Recruiting
Phase 3

Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia

Iron Deficiency, Anaemia in Children
Pharmacosmos A/S200 enrolled1 locationNCT05179226
Recruiting
Not Applicable

A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia

Aplastic Anaemia
The First Affiliated Hospital of Soochow University224 enrolled4 locationsNCT07499284
Recruiting

Adverse Effects of ATG/ALG Therapy in Aplastic Anemia

Aplastic Anaemia
Institute of Hematology & Blood Diseases Hospital, China200 enrolled1 locationNCT07461116
Recruiting

Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.

ChemotherapyCancerChemotherapy-induced Neutropenia+3 more
Pomeranian Medical University Szczecin265 enrolled5 locationsNCT06809101
Recruiting
Phase 2

Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery

Cardiac SurgeryChronic Iron Deficiency Anaemia
University Health Network, Toronto60 enrolled3 locationsNCT06287619
Recruiting
Phase 4

Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis

Dialysis; ComplicationsChronic Kidney Disease 5DRenal Anemia of Chronic Kidney Disease+2 more
Chinese PLA General Hospital240 enrolled1 locationNCT07045155
Recruiting

Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.

Pain, PostoperativeCystectomyAnaemia+3 more
Goethe University60 enrolled1 locationNCT07008261
Recruiting

Non-invasive Detection of Iron Deficiency in Obstetrics

Iron-deficiencyPostpartum DepressionIron Deficiency Anemia of Pregnancy+5 more
Wuerzburg University Hospital500 enrolled1 locationNCT07083492
Recruiting
Phase 4

Post-discharge Malaria Chemoprevention Implementation Trial in Benin

Severe MalariaSevere Anaemia
Institut de Recherche Clinique du Benin648 enrolled2 locationsNCT06601712
Recruiting
Phase 3

Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge

MalariaSevere MalariaSevere Anaemia+1 more
Liverpool School of Tropical Medicine398 enrolled2 locationsNCT07082205
Recruiting
Phase 2

Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia

Elderly (People Aged 65 or More)Sever Aplastic AnaemiaImmunosuppressive Treatment
Institute of Hematology & Blood Diseases Hospital, China65 enrolled1 locationNCT07010237
Recruiting
Phase 2

Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A

Aplastic Anaemia
Peking Union Medical College Hospital40 enrolled1 locationNCT06802055
Recruiting
Phase 3

Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy

Iron Deficiency Anaemia in Childbirth
Saskatchewan Health Authority - Regina Area280 enrolled1 locationNCT05251493
Recruiting

Maternal Iron Deficiency and Childhood Health

Iron statusIron deficiency in pregnancyIron-deficiency+2 more
Tampere University Hospital6,000 enrolled1 locationNCT06879080
Recruiting
Not Applicable

Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients

Iron-Deficiency AnemiaIron Deficiency, Anaemia in Children
Arooj Khan198 enrolled1 locationNCT06742528
Recruiting
Not Applicable

Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)

Extremely Low Birth WeightPremature infantsVery Low Birth Weight Infant+2 more
CHRISTUS Health100 enrolled1 locationNCT06555315